Profile: Cephalon, Inc. is involved in discovering and delivering new therapies to improve patient health. We provide treatments for central nervous system disorders, pain, and cancer. Our products include treanda®, amrix®, provigil®, fentora®, trisenox®, vivitrol®, gabitril®, actiq® and nuvigil®. Treanda® is a chemotherapeutic agent approved for the treatment of chronic lymphocytic leukemia (CLL), a slowly progressing cancer of blood and bone marrow. This product may destroy cancer cells by damaging the DNA in cancer cells and by disrupting normal cell division. Amrix® is a skeletal muscle relaxant indicated as an adjunct to rest & physical therapy for the relief of muscle spasm associated with acute, painful musculoskeletal conditions. Provigil® is approved for the treatment of excessive daytime sleepiness associated with narcolepsy. Fentora® is the buccal tablet indicated for the management of breakthrough pain in opioid-tolerant patients with cancer. Abitril® is indicated as an adjunct therapy for the treatment of partial seizures associated with epilepsy. Actiq® is approved for the treatment of breakthrough pain in opioid-tolerant cancer patients.